These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17606704)

  • 1. Triggering tumor immunity through angiogenesis targeting.
    Jinushi M; Dranoff G
    Clin Cancer Res; 2007 Jul; 13(13):3762-4. PubMed ID: 17606704
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer: looking outside the genome.
    Folkman J; Hahnfeldt P; Hlatky L
    Nat Rev Mol Cell Biol; 2000 Oct; 1(1):76-9. PubMed ID: 11413493
    [No Abstract]   [Full Text] [Related]  

  • 3. Endogenous inhibitors of angiogenesis.
    Folkman J
    Harvey Lect; 1996-1997; 92():65-82. PubMed ID: 15372744
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular mechanisms and therapeutic development of angiogenesis inhibitors.
    Cao Y
    Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic therapy and p53.
    Hammond EM; Giaccia AJ
    Science; 2002 Jul; 297(5581):471; discussion 471. PubMed ID: 12142499
    [No Abstract]   [Full Text] [Related]  

  • 6. Thalidomide: dual benefits in palliative medicine and oncology.
    Davis MP; Dickerson ED
    Am J Hosp Palliat Care; 2001; 18(5):347-51. PubMed ID: 11565189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chapter 6. Mouse models to investigate anti-cancer effects of VEGF inhibitors.
    Crawford Y; Ferrara N
    Methods Enzymol; 2008; 445():125-39. PubMed ID: 19022058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting vessel abnormalization in cancer.
    Garber K
    J Natl Cancer Inst; 2007 Jul; 99(13):991-2, 995. PubMed ID: 17596567
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor necrosis factor-mediated interactions between inflammatory response and tumor vascular bed.
    ten Hagen TL; Seynhaeve AL; Eggermont AM
    Immunol Rev; 2008 Apr; 222():299-315. PubMed ID: 18364010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F; Ferrara N
    Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of the VEGF receptor system with tyrosine kinase inhibitors. Angiogenesis inhibition in oncology].
    Mross K
    Pharm Unserer Zeit; 2008; 37(5):404-15. PubMed ID: 18729270
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neoplasms under control with the help of vascular treatment?].
    Laurén J; Alitalo K
    Duodecim; 2000; 116(7):705-11. PubMed ID: 12078136
    [No Abstract]   [Full Text] [Related]  

  • 13. [Angiogenesis: all a radiation oncologist should know].
    Mazeron R; Bourhis J; Deutsch E
    Cancer Radiother; 2008 Jan; 12(1):50-60. PubMed ID: 18243753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting vessels to treat hepatocellular carcinoma.
    Romanque P; Piguet AC; Dufour JF
    Clin Sci (Lond); 2008 Apr; 114(7):467-77. PubMed ID: 18302534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of angiogenesis inhibitory combination therapies for treatment of renal cell carcinoma].
    Bartsch G; Eggert K; Soker S; Fiedler W; Laack E; Volkmer BG; Gschwend J; Bokemeyer C; Hautmann R; Schuch G
    Urologe A; 2007 Sep; 46(9):1289-90. PubMed ID: 17624513
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antibody therapy in hematology and oncology--2].
    Kneba M; Schrader C; Köhne H
    Med Klin (Munich); 2009 Jan; 104(1):28-49. PubMed ID: 19142594
    [No Abstract]   [Full Text] [Related]  

  • 17. [Systemic and cellular pathways of anti-tumor action of plant adaptogenes].
    Arushanian EB
    Vopr Onkol; 2009; 55(1):15-23. PubMed ID: 19435193
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic strategies using inhibitors of angiogenesis.
    O'Reilly MS
    Methods Mol Biol; 2003; 223():599-634. PubMed ID: 12777753
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitors of angiogenesis: new hopes for oncologists, new challenges for anesthesiologists.
    Libert N; Tourtier JP; Védrine L; Chargari C
    Anesthesiology; 2010 Sep; 113(3):704-12. PubMed ID: 20693871
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor angiogenesis--a potential target in cancer chemoprevention.
    Bhat TA; Singh RP
    Food Chem Toxicol; 2008 Apr; 46(4):1334-45. PubMed ID: 17919802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.